GSK580299 (HPV vaccine, adsorbed, types 16 and 18)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK580299 (HPV vaccine, adsorbed, types 16 and 18), covering 2020-12-19 to 2020-12-19. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study [Phase 4]